AHA Statement On Improving the Coordination and Quality of Substance Use Disorder Treatment

AHA Statement Before the Committee on Commerce: Improving the Coordination and Quality of Substance Use Disorder Treatment

AHA expresses strong support for legislation that would allow responsible sharing of patient substance use disorder (SUD) treatment information and prevent inappropriate and dangerous prescribing of opioids by amending 42 CFR Part 2 to align with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment and health care operations.

Related Resources

Toolkits/Methodology
Strengthening the Health Care Workforce Digital Toolkit contains social media posts and images to support your team through burnout, to address behavioral…
Guides/Reports
As we chart a new path together, we have developed this new resource – under the guidance of the AHA Board of Trustees’ Task Force on Workforce and with input…
Fact Sheets
The AHA urges Congress and the Biden Administration to prioritize funding for the infrastructure that supports the health care workforce needs of the country…
Advancing Health Podcast
Public
Leading care teams through COVID-19 has been a challenge unlike any other.
Fact Sheets
Public
Congress should enact the Safety from Violence for Healthcare Employees (SAVE) Act, which provides health care workplace protections against violence similar…
Letter/Comment
Public
AHA provides feedback on the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act (S.4348).